Will an HIV RNA (viral load) test detect HIV infection eight months after exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Will HIV RNA Detect HIV 8 Months Post-Exposure?

Yes, an HIV RNA (viral load) test will absolutely detect HIV infection eight months after exposure if infection occurred—this timeframe is far beyond any window period for HIV detection.

Understanding the Detection Timeline

At 8 months post-exposure, you are well past all detection windows for HIV testing. Here's why this timing makes detection highly reliable:

Early Detection Windows (For Context)

According to IDSA/ASM guidelines, HIV markers appear in a predictable sequence after infection 1:

  • HIV RNA becomes detectable first: 10-14 days after infection (preceded by a 3-5 day lead over p24 antigen)
  • p24 antigen: Detectable at 14-22 days
  • Antibodies: Typically within 4 weeks of exposure
  • Fourth-generation tests (antibody + p24 antigen): Positive at 4-7 days after detectable virus

Research confirms the eclipse period (exposure to detectable infection) averages only 8-10 days 2.

Your 8-Month Timeline

At 8 months (approximately 240 days) post-exposure, you are more than 30 times beyond the longest window period. The U.S. Public Health Service guidelines recommend HIV antibody testing for only 6 months post-exposure 3, meaning your timeframe exceeds even the most conservative follow-up recommendations.

What the Test Will Show

If HIV infection occurred from that exposure:

  • HIV RNA will be detectable at viral loads typically ranging from thousands to millions of copies/mL in untreated infection 1
  • The viral load would have been detectable for approximately 7.5 months already
  • Antibody tests would also be positive (having seroconverted months ago)

Research shows that plasma HIV RNA below 40 copies/mL is rare in untreated persons, even in early infection 4. Without treatment, viral loads naturally increase over time at approximately 0.11 log10 per year 5.

Important Caveats

The Test Has Limitations for Diagnosis

HIV RNA tests are NOT FDA-approved for diagnosing HIV infection 1, 6. They are designed for monitoring viral load in known HIV-positive patients. Outside acute infection settings, viral load assays should be used cautiously for diagnosis because:

  • False positives can occur (typically <5,000 copies/mL)
  • Low copy number results require retesting of a second specimen 1

Proper Diagnostic Approach at 8 Months

The appropriate test at 8 months post-exposure is a fourth-generation HIV antibody/antigen combination test, not an HIV RNA test 1. This is because:

  • Antibodies are definitively present by this time if infection occurred
  • Fourth-generation tests are the recommended screening method
  • They are more cost-effective and appropriate for diagnostic purposes
  • HIV RNA testing is unnecessary at this late timeframe

One Critical Exception

If you have been on antiretroviral therapy or post-exposure prophylaxis (PEP), this changes everything. NAAT (including HIV RNA tests) is not 100% sensitive in individuals with viral suppression, either naturally or therapeutically 1. PrEP can suppress viral load and delay seroconversion by approximately 7 days, though NAT still detects infection in ~90% of cases 7.

Bottom Line

If you were exposed 8 months ago and have not been on any HIV medications, an HIV RNA test will detect infection if it occurred—but you should actually be getting a standard fourth-generation antibody/antigen test instead, as this is the appropriate diagnostic test for your timeframe. If that test is negative at 8 months post-exposure with no intervening high-risk exposures, you can be confident that the exposure in question did not result in HIV infection.

Related Questions

Is a negative HIV‑RNA test performed 20 days after two unprotected insertive exposures reliable, and is it appropriate to wait a year before retesting given I am not on PEP or PrEP and have had no further exposures?
As the insertive partner in two unprotected vaginal exposures, with a negative HIV RNA test 20 days after the last exposure (100 % sensitivity), no further exposures, and not on PrEP, can I trust that this result is reliable and that a fourth‑generation antigen/antibody test done 125 days post‑exposure will remain negative?
Is a negative HIV RNA (viral load) test performed 20 days after my most recent exposure reliable enough to forgo an additional annual HIV screening, given I have had no further exposures, am not on pre‑exposure prophylaxis, and was the insertive partner?
How reliable is a negative HIV RNA test performed 20 days after unprotected insertive exposure, and what is the probability that a later test could turn positive?
Will a fourth-generation HIV assay performed at 70 days post‑exposure be positive after a negative HIV RNA test at 20 days, given a single episode of unprotected vaginal intercourse and no pre‑exposure prophylaxis (PrEP) use?
At what hemoglobin level should Retacrit (epoetin alfa) be held?
Should tirzepatide be started in a patient with an active infection, and what precautions are required?
How should a postoperative fluid collection at the base of the neck following shoulder arthroscopy be evaluated and managed?
What is an appropriate taper‑off schedule for an adult stable on Caplyta (lumateperone) 10.5 mg taken at bedtime?
Can doxycycline be used to treat a vaginal boil in an adult non‑pregnant woman?
How does donepezil worsen behavior in patients with frontotemporal dementia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.